Brain Injury Clinical Trial
Official title:
Vestibular Consequences of Blast-related Mild Traumatic Brain Injury
NCT number | NCT01021137 |
Other study ID # | C6841-R |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 1, 2011 |
Est. completion date | December 2017 |
Verified date | June 2019 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this project is to determine the effects of mild traumatic brain injury and blast exposure on the inner ear balance and central nervous systems.
Status | Completed |
Enrollment | 140 |
Est. completion date | December 2017 |
Est. primary completion date | December 30, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Complaint of dizziness and/or imbalance - History of blast exposure - Diagnosis of mild traumatic brain injury Exclusion Criteria: - Prior history of vestibular or neurological disorder - Presence of internal metal - Pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Mountain Home VA Medical Center James H. Quillen VA Medical Center, Mountain Home, TN | Mountain Home | Tennessee |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Peripheral Vestibular Function (Vestibulo-ocular Reflex/Semicircular Canal): Caloric Weakness | The caloric weakness was determined using monothermal warm inter-ear difference (MWIED) which was calculated as: (|RW| - |LW| )/( |RW| + |LW|) x 100, where RW = the maximum slow phase velocity (SPV) of nystagmus induced by warm water irrigation in the right ear and LW = the maximum SPV of nystagmus induced by warm water irrigation in the left ear. For participants with MWIED > 10, then cool caloric irrigation was also performed and caloric weakness was determined using a bithermal inter-ear difference (BIED) calculated as: (|RW| + |RC|) - (|LW| + |LC|) / (|RW| + |RC| + |LW| + |LC|) x 100, where RC = maximum SPV of nystagmus induced by cool water irrigation in the right ear and LC = maximum SPV of nystagmus induced by cool water irrigation in the left ear. | up to 30 minutes | |
Primary | Rotary Chair Slow Harmonic Acceleration (SHA) Gain | Rotary chair slow harmonic acceleration (SHA) vestibulo-ocular reflex (VOR) gain at 0.01 Hz was used as a measure of peripheral vestibular function (VOR/horizontal semicircular canal). VOR gain is defined as the ratio of the slow component velocity eye movement (output) to the velocity of the head movement (input). | up to 30 minutes | |
Primary | Peripheral Vestibular Function (Saccular-collic Pathway): Cervical Vestibular Evoked Potential (cVEMP) | Air-conducted cervical vestibular evoked potential (cVEMP) inter-ear amplitude asymmetry ratio was used as a measure of otolith organ function (saccular-collic pathway). Inter-ear amplitude asymmetry ratio was calculated as: [(|L_P1-N1| - |R_P1-N1|)/ (|L_P1-N1| + |R_P1-N1|)] x100, where L_P1-N1 = peak-to-peak cVEMP amplitude of the left side and R_P1-N1 = peak-to-peak cVEMP amplitude of the right side. The amplitudes were calculated from cVEMP responses at a stimulus intensity of 120 dB peakSPL. The criterion for abnormal cVEMP was defined as an absent cVEMP or a corrected cVEMP amplitude asymmetry ratio greater than or equal to 40%, either of which would indicate a unilateral vestibular loss. A bilateral vestibular loss was indicated by absent cVEMPs bilaterally. | Up to 30 minutes | |
Primary | Rotary Chair Slow Harmonic Acceleration (SHA) Phase | Rotary chair slow harmonic acceleration (SHA) vestibulo-ocular reflex (VOR) phase at 0.01 Hz was used as a measure of peripheral vestibular function (VOR/horizontal semicircular canal). The phase is the timing difference between the velocity of head movement and the slow-phase eye velocity. This parameter is normalized for a full cycle of a sinusoid (360 degrees) and presented in an angular unit of degrees rather than a unit of time. For perfectly compensatory eye movements the phase is 0 degrees, meaning there is no difference between the actual eye velocity and the ideal VOR (by convention, degrees is added to the phase so that the comparison is based on the ideal VOR responses instead of the actual head motion). | Up to 30 minutes (SHA phase is obtained simultaneously with SHA gain) | |
Primary | Peripheral Vestibular Function (Utricular-ocular Pathway): Ocular Vestibular Evoked Potential (oVEMP) | Bone-conducted ocular vestibular evoked potential (oVEMP) inter-ear amplitude asymmetry ratio was used as a measure of otolith organ function (utricular-ocular pathway). Inter-ear amplitude asymmetry ratio was calculated as: [(|L_N1-P1| - |R_N1-P1|)/ (|L_N1-P1| + |R_N1-P1|)] x100, where L_N1-P1 = peak-to-peak oVEMP amplitude of the left eye/right ear and R_N1-P1 = peak-to-peak oVEMP amplitude of the right eye/left ear. The oVEMP is a contralateral response; therefore, recordings from the left eye reflect the response of the right ear and vice versa. The amplitudes were calculated from oVEMP responses at a stimulus intensity of 155 dB peakFL. The criterion for abnormal oVEMP was defined as an absent oVEMP or a corrected oVEMP amplitude asymmetry ratio greater than or equal to 40%, either of which would indicate a unilateral vestibular loss. A bilateral vestibular loss was indicated by absent oVEMPs bilaterally. | Up to 20 minutes | |
Secondary | Central Vestibular/Central Nervous System (CNS) Function: Visual Fixation Suppression | Visual fixation suppression was used as a measure of central vestibular/CNS function. Visual fixation suppression is a measure of vestibulo-ocular reflex (VOR) gain obtained during visual fixation at 0.16 Hz slow harmonic acceleration on the rotary chair. VOR gain was defined as the ratio of the slow component velocity eye movement (output) to the velocity of the head movement (input). Visual fixation suppression was considered normal if VOR gain is suppressed > 50% with visual fixation compared to no fixation. | 1 minute | |
Secondary | Postural Stability: Sensory Organization Test (SOT) | This measure is the composite equilibrium score from six conditions of the sensory organization test obtained with the Neurocom Equitest. Results of the SOT were calculated based on maximum peak-to-peak anterior-posterior sway expressed as an equilibrium score ranging from 0 to 100, with 0 indicating loss of balance (i.e., required support of harness, took a step, touched walls for support or opened eyes in eyes closed conditions) and 100 indicating perfect stability. The outcome measure was the equilibrium composite score and was calculated by the software as the weighted average of the equilibrium scores for the six conditions. For ages 18-59 years, the normative value (mean - 1.67 SD) for the composite score is at least 70 (NeuroCom, 2011). | Up to 20 minutes | |
Secondary | Dizziness Handicap Inventory | The Dizziness Handicap Inventory (DHI) was used as a quality of life measure.The DHI measures the subject's self-perceived dizziness. The scale has 25 questions with 3 possible answers each: "Yes" = 4 points, "Sometimes" = 2 points, and "No" = 0 points. The minimum number of points that a subject can score is 0 and the maximum number of points is 100. The subject's self-perceived dizziness is reported as a percentage with a range of 0-100%, and is calculated by: subject's total number of points/maximum number of points (100) x 100%. The higher the score on the DHI, the worse a patient's self-perceived dizziness. | Up to 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02710123 -
Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion
|
N/A | |
Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
Completed |
NCT02262286 -
MIND (Management of Traumatic Brain Injury Diagnosis)
|
N/A | |
Completed |
NCT01461902 -
Vasospasm in Pediatric Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT01198964 -
Optimization of Human Cortical Stimulation
|
||
Active, not recruiting |
NCT01207050 -
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
|
Phase 4 | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 | |
Completed |
NCT00875329 -
Traumatic Brain Injury (TBI) Screening Instruments
|
N/A | |
Completed |
NCT01059890 -
Cerebral Antibiotics Distribution After Acute Brain Injury
|
Phase 1 | |
Completed |
NCT01035606 -
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
|
N/A | |
Completed |
NCT00596765 -
Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury
|
N/A | |
Completed |
NCT00571623 -
Automated Chest Physiotherapy to Improve Outcomes in Neuro
|
N/A | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 | |
Recruiting |
NCT05105763 -
Biofeedback Gait Retraining for Stiff Knee Gait Correction
|
N/A | |
Recruiting |
NCT02495558 -
Cough Assessment in Patients With Severe Acquired Brain Injury
|
N/A | |
Completed |
NCT02100592 -
Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study
|
Phase 1/Phase 2 | |
Completed |
NCT00797680 -
Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest
|
Phase 2 | |
Completed |
NCT00018499 -
Genotype Influence on Recovery After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT02567201 -
Electrophysiological Evaluation of Voluntary Attention
|
N/A | |
Withdrawn |
NCT05581927 -
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A |